|
|
Volumn 2012, Issue , 2012, Pages 444-449
|
|
Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
RECOMBINANT PROTEIN;
RITUXIMAB;
THROMBOPOIETIN;
ADOLESCENT;
BLEEDING;
CHILD;
HEMATOLOGY;
HUMAN;
IDIOPATHIC THROMBOCYTOPENIC PURPURA;
INFANT;
METHODOLOGY;
PATHOLOGY;
PEDIATRICS;
PRESCHOOL CHILD;
REVIEW;
SPLENECTOMY;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
ADOLESCENT;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
CHILD;
CHILD, PRESCHOOL;
HEMATOLOGY;
HEMORRHAGE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFANT;
PEDIATRICS;
PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;
RECOMBINANT PROTEINS;
SPLENECTOMY;
THROMBOCYTOPENIA;
THROMBOPOIETIN;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 84879363483
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation.v2012.1.444.3806864 Document Type: Review |
|
Times cited : (17)
|
|
References (0)
|
